​

Supernus Pharmaceuticals Ownership | Who Owns Supernus Pharmaceuticals?


OverviewForecastRevenueFinancialsChartTranscripts

Supernus Pharmaceuticals Ownership Summary


Supernus Pharmaceuticals is owned by 104.62% institutional investors, 4.46% insiders. Blackrock is the largest institutional shareholder, holding 18.90% of SUPN shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 6.07% of its assets in Supernus Pharmaceuticals shares.

SUPN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockSupernus Pharmaceuticals104.62%4.46%-9.07%
SectorHealthcare Stocks 245.07%12.10%-157.17%
IndustrySpecialty & Generic Drug Manufacturers Stocks37.12%13.99%48.89%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock10.39M18.90%$278.00M
Blackrock funding, inc. /de9.35M16.22%$434.87M
Vanguard group6.05M10.72%$300.61M
Millennium management3.85M6.68%$179.21M
Armistice capital2.65M4.59%$123.07M
Vanguard capital management2.52M4.37%$117.05M
State street2.46M4.27%$114.41M
Macquarie management2.38M4.13%$110.62M
Dimensional fund advisors lp2.08M3.60%$96.65M
Geode capital management1.57M2.72%$73.04M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Krensavage asset management280.68K4.96%$13.05M
Ashford capital management645.38K4.12%$33.36M
Sofinnova investments1.04M2.49%$48.20M
Bruce150.00K1.89%$6.98M
Villanova investment management34.93K1.54%$1.62M
Armistice capital2.65M1.51%$123.07M
Third avenue management152.72K1.14%$7.10M
Rice hall james & associates490.22K1.11%$22.80M
Soleus capital management520.00K0.83%$24.19M
Bridge city capital78.17K0.83%$3.64M

Top Buyers

HolderShares% AssetsChange
Two sigma investments, lp1.18M0.04%913.15K
Armistice capital2.65M1.51%750.85K
Sixth street partners management company703.55K0.00%703.55K
Blackrock funding, inc. /de9.35M0.01%552.79K
Millennium management3.85M0.06%537.24K

Top Sellers

HolderShares% AssetsChange
Macquarie group---2.53M
Point72 asset management---1.32M
Polar capital---1.00M
Rubric capital management lp---595.37K
Assenagon asset management73.17K0.00%-457.44K

New Positions

HolderShares% AssetsChangeValue
Sixth street partners management company703.55K0.00%703.55K$32.72M
Soleus capital management520.00K0.83%520.00K$24.19M
Norges bank120.40K0.00%120.40K$5.98M
Hillsdale investment management103.68K0.11%103.68K$4.82M
Jump financial100.60K0.04%100.60K$4.68M

Sold Out

HolderChange
Claris advisors, llc / mo /-1.00
Dunhill financial-1.00
Td capital management-2.00
Global financial private client-3.00
Abound wealth management-4.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 2026334-60,308,8773.59%1040.98%1663.75%109-6.84%
Mar 31, 2026324-4.71%57,151,5250.06%1010.99%157-11.30%112-
Dec 31, 2025199-36.01%31,720,915-45.01%560.53%101-32.67%55-52.99%
Sep 30, 2025175-38.60%28,258,627-50.30%500.49%77-51.88%65-18.75%
Jun 30, 2025290-59,380,9950.51%1050.95%16311.64%80-15.79%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
iShares Core S&P Small-Cap ETF3.53M6.07%-3.15K
Delaware Small Cap Core I2.00M3.62%-12.37K
Macquarie Small Cap Core I1.94M3.46%-145.53K
Nomura US Small Cap Core Equity1.92M3.30%441.56K
Nomura Small Cap Core I1.92M3.30%488.39K
Vanguard MStar Total Stk Mkt Idx Invest1.76M3.02%8.73K
Vanguard Morn Total Stk Mkt Idx Investor1.75M3.02%8.50K
Vanguard Total Stock Mkt Idx Inv1.75M3.02%8.50K
Vanguard US Total Market Shares ETF1.68M3.00%1.91K
iShares Russell 2000 ETF1.43M2.46%-25.34K

Recent Insider Transactions


DateNameRoleActivityValue
Mar 17, 2026Bhatt Padmanabh P. Sr. VP of IP, CSOSell$1.13M
Mar 17, 2026Bhatt Padmanabh P. Sr. VP of IP, CSOSell$1.38M
Mar 16, 2026Bhatt Padmanabh P. Sr. VP of IP, CSOSell$1.71M
Mar 18, 2026Bhatt Padmanabh P. Sr. VP of IP, CSOSell$338.82K
Mar 16, 2026Bhatt Padmanabh P. Sr. VP of IP, CSOSell$802.08K

Insider Transactions Trends


DateBuySell
2026 Q3--
2026 Q1-17
2025 Q4-9
2025 Q3-21
2025 Q2--

SUPN Ownership FAQ


Who Owns Supernus Pharmaceuticals?

Supernus Pharmaceuticals shareholders are primarily institutional investors at 104.62%, followed by 4.46% insiders and -9.08% retail investors. The average institutional ownership in Supernus Pharmaceuticals's industry, Specialty & Generic Drug Manufacturers Stocks, is 37.12%, which Supernus Pharmaceuticals exceeds.

Who owns the most shares of Supernus Pharmaceuticals?

Supernus Pharmaceuticals’s largest shareholders are Blackrock (10.39M shares, 18.90%), Blackrock funding, inc. /de (9.35M shares, 16.22%), and Vanguard group (6.05M shares, 10.72%). Together, they hold 45.85% of Supernus Pharmaceuticals’s total shares outstanding.

Does Blackrock own Supernus Pharmaceuticals?

Yes, BlackRock owns 18.90% of Supernus Pharmaceuticals, totaling 10.39M shares as of Jun 2024. This represents 0.01% of BlackRock's total assets, with a market value of 278M$. In the last quarter, BlackRock increased its holdings by 30.28K shares, a 0.29% change.

Who is Supernus Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Krensavage asset management is Supernus Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 4.96% of its assets in 280.68K Supernus Pharmaceuticals shares, valued at 13.05M$.

Who is the top mutual fund holder of Supernus Pharmaceuticals shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Supernus Pharmaceuticals shares, with 6.07% of its total shares outstanding invested in 3.53M Supernus Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools